▶주메뉴 바로가기

▶본문 바로가기

THE INVESTOR
December 13, 2018
Big Reunion

Bio & Medicine

Humedix gets approval for salmon-based wound healing booster

  • PUBLISHED :April 16, 2018 - 16:13
  • UPDATED :April 16, 2018 - 16:13
  • 폰트작게
  • 폰트크게
  • facebook
  • twitter
  • sms
  • print

[THE INVESTOR] Humedix, a subsidiary of Huons Global, said on April 16 that it has obtained sales approval for two types of injection therapies that repair damaged skin and encourage wound healing.

The products -- Revitalrex and Revitalrex prefilled syringe -- are based on Polydeoxyribonucleotide, or PDRN, which is extracted from salmon trout sperm and is being used for cell regeneration in various medical fields including dermatology. 


Humedix headquarters



“Revitalrex is a key product that will lead Humedix’s mid- to long-term growth. We plan to expand our portfolio to aesthetics sector including skin care and cosmetic medical devices as well as arthritis treatment,” said Humedix CEO Jung Gu-wan in a statement.

With the approval, Humedix is beefing up its pipeline mainly depended on hyaluronic acid injections for rheumatoid arthritis and dermal fillers.

By Park Han-na (hnpark@heraldcorp.com)

  • facebook
  • twitter
  • sms
  • print

EDITOR'S PICKS